- Home
- OLP vs ARCT Comparison
OLP vs ARCT Comparison
Compare OLP & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OLP
- ARCT
- Stock Information
- Founded
- OLP 1982
- ARCT 2013
- Country
- OLP United States
- ARCT United States
- Employees
- OLP N/A
- ARCT N/A
- Industry
- OLP Real Estate Investment Trusts
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- OLP Real Estate
- ARCT Health Care
- Exchange
- OLP Nasdaq
- ARCT Nasdaq
- Market Cap
- OLP 569.9M
- ARCT 298.3M
- IPO Year
- OLP N/A
- ARCT N/A
- Fundamental
- Price
- OLP $24.20
- ARCT $13.62
- Analyst Decision
- OLP Strong Buy
- ARCT Strong Buy
- Analyst Count
- OLP 1
- ARCT 8
- Target Price
- OLP $28.00
- ARCT $52.83
- AVG Volume (30 Days)
- OLP 73.4K
- ARCT 480.2K
- Earning Date
- OLP 08-05-2025
- ARCT 08-04-2025
- Dividend Yield
- OLP 7.42%
- ARCT N/A
- EPS Growth
- OLP N/A
- ARCT N/A
- EPS
- OLP 1.35
- ARCT N/A
- Revenue
- OLP $92,152,000.00
- ARCT $143,680,000.00
- Revenue This Year
- OLP $11.87
- ARCT N/A
- Revenue Next Year
- OLP $4.72
- ARCT $34.79
- P/E Ratio
- OLP $18.00
- ARCT N/A
- Revenue Growth
- OLP 3.31
- ARCT 15.38
- 52 Week Low
- OLP $22.32
- ARCT $8.04
- 52 Week High
- OLP $30.45
- ARCT $25.88
- Technical
- Relative Strength Index (RSI)
- OLP 45.57
- ARCT 56.99
- Support Level
- OLP $23.55
- ARCT $12.65
- Resistance Level
- OLP $24.55
- ARCT $14.58
- Average True Range (ATR)
- OLP 0.53
- ARCT 0.97
- MACD
- OLP -0.13
- ARCT 0.04
- Stochastic Oscillator
- OLP 33.16
- ARCT 58.76
About OLP One Liberty Properties Inc.
One Liberty Properties Inc is a self-administered and self-managed real estate investment trust. It acquires, owns, and manages a geographically diversified portfolio consisting mainly of industrial and, to a lesser extent, retail properties, many of which are subject to long-term net leases. The trust has approximately one hundred two properties located across several states in the United States of America. A majority of its revenue is generated in the form of rental income.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.